182 related articles for article (PubMed ID: 38612496)
1. Impact of
Soria-Chacartegui P; Navares-Gómez M; Molina-Jiménez F; Laserna-Mendieta EJ; Arias-González L; Majano P; Casabona S; Lucendo AJ; Abad-Santos F; Santander C; Zubiaur P
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612496
[TBL] [Abstract][Full Text] [Related]
2. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
[TBL] [Abstract][Full Text] [Related]
3. STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy.
Mougey EB; Nguyen V; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Borrell B; Román E; González-Lois C; Chao M; Al-Atrash H; Franciosi JP
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2046-2053.e2. PubMed ID: 32798708
[TBL] [Abstract][Full Text] [Related]
4. ACCURACY OF THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN CHILDREN.
Ribeiro LM; Vieira MC; Truppel SK; Rosário Filho NA
Arq Gastroenterol; 2024; 61():e23103. PubMed ID: 38451662
[TBL] [Abstract][Full Text] [Related]
5. Baseline Peripheral Eosinophil Count Independently Predicts Proton Pump Inhibitor Response in Eosinophilic Esophagitis.
Muftah M; Barshop K; Redd WD; Goldin AH; Lo WK; Chan WW
J Clin Gastroenterol; 2024 Mar; 58(3):242-246. PubMed ID: 36943488
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.
Zhang X; Cheng E; Huo X; Yu C; Zhang Q; Pham TH; Wang DH; Spechler SJ; Souza RF
PLoS One; 2012; 7(11):e50037. PubMed ID: 23185525
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and Treatment of Eosinophilic Esophagitis].
Kim SJ; Choi CW; Hwang CS
Korean J Gastroenterol; 2022 Mar; 79(3):99-108. PubMed ID: 35342167
[TBL] [Abstract][Full Text] [Related]
8. Responses of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers According to Outcomes of Symptom, Endoscopy, and Histology in Patients With Eosinophilic Esophagitis.
Fujiwara Y; Sawada A; Ominami M; Fukunaga S; Otani K; Hosomi S; Nagami Y; Taira K; Tanaka F
J Clin Gastroenterol; 2024 Apr; 58(4):337-341. PubMed ID: 37267311
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy.
Visaggi P; Baiano Svizzero F; Del Corso G; Bellini M; Savarino E; de Bortoli N
Am J Gastroenterol; 2022 Oct; 117(10):1702-1705. PubMed ID: 36087067
[TBL] [Abstract][Full Text] [Related]
10. Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis.
Muftah M; Hartnett DA; Flanagan R; Redd WD; Jenkins A; Goldin AH; Hsu Blatman K; Chan WW
J Gastroenterol Hepatol; 2024 Apr; 39(4):701-707. PubMed ID: 38185799
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
[TBL] [Abstract][Full Text] [Related]
14. Proton-Pump Inhibitors in Eosinophilic Esophagitis: A Review Focused on the Role of Pharmacogenetics.
Rodríguez-Alcolado L; Navarro P; Arias-González L; Grueso-Navarro E; Lucendo AJ; Laserna-Mendieta EJ
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675148
[TBL] [Abstract][Full Text] [Related]
15. [Eosinophilic oesophagitis in children].
Nielsen MH; Bredal K; Terkelsen JH; Kristiansen DM; Krarup AL
Ugeskr Laeger; 2022 Aug; 184(31):. PubMed ID: 35959825
[TBL] [Abstract][Full Text] [Related]
16. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
[TBL] [Abstract][Full Text] [Related]
17. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
18. Addressing diagnostic dilemmas in eosinophilic esophagitis using esophageal epithelial eosinophil-derived neurotoxin.
Thomas J; Hopson P; Deb C; Bornstein J; Mehta D; Bittar K; Smadi Y
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):304-312. PubMed ID: 38374551
[TBL] [Abstract][Full Text] [Related]
19. Composite score of physiomechanical esophageal function using functional lumen imaging probe panometry in eosinophilic esophagitis.
Carlson DA; Hirano I; Gonsalves N; Kahrilas PJ; Araujo IK; Yang M; Tetreault MP; Pandolfino JE
Gastrointest Endosc; 2024 Apr; 99(4):499-510.e1. PubMed ID: 37890596
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis.
Thakkar KP; Fowler M; Keene S; Iuga A; Dellon ES
Dig Liver Dis; 2022 Sep; 54(9):1179-1185. PubMed ID: 35410852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
